Business
Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments
BOCA RATON, Fla., May 01, 2025--May is Skin Cancer Awareness Month and Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, is leveraging a wide range of activities to draw attention to the importance of prevention, early detection and treatment of the most common form of cancer that affects millions of people worldwide.
About this update from Sensus Healthcare, Inc.
[{"type":"text","content":"Innovative SRT-100 Vision (IG-SRT) and SRT Vision Technologies allow dermatologists to treat non-melanoma skin cancer without surgery or patient downtime","length":153,"tagName":"p","attribs":{}},{"type":"text","content":"BOCA RATON, Fla., May 01, 2025--(BUSINESS WIRE)--May is Skin Cancer Awareness Month and Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, is leveraging a wide range of activities to draw attention to the importance of prevention, early detection and treatment of the most common form of cancer that affects millions of people worldwide.","length":501,"tagName":"p","attribs":{}},{"type":"text","content":"Throughout the month of May, Sensus Healthcare is actively promoting skin cancer awareness through educational newsletters, social media campaigns and collaborations with dermatologists and other healthcare professionals. The Company also offers valuable resources and insights on its website to empower individuals to recognize the early warning signs of skin cancer and understand the benefits of non-invasive treatment.","length":422,"tagName":"p"},{"type":"text","content":""With the number of skin cancer cases on the rise, awareness and access to patient-friendly, non-invasive treatment options are more critical than ever," said Joe Sardano, CEO of Sensus Healthcare. "Our IG-SRT and SRT technologies exemplify our commitment to providing healthcare professionals with the tools they need to effectively treat skin cancer while prioritizing patient comfort and preserving healthy tissue."","length":438,"tagName":"p"},{"type":"text","content":"IG-SRT and SRT-100 Vision, Sensus’ flagship products that provide effective, non-invasive treatment options for non-melanoma skin cancers, are at the forefront of the Company’s solutions to help patients achieve optimal outcomes with minimal side effects and no downtime. IG-SRT delivers precise, targeted radiation while the SRT-100 Vision integrates high-frequency ultrasound imaging for a precise treatment and an improved patient experience.","length":445,"tagName":"p"},{"type":"text","content":"In conjunction with its focus on skin cancer awareness and education, and to expand access to its technol...